Summary
Keratin was identified with the aid of polyclonal antisera in the cytoplasm in over 90% of the transitional cell carcinomas investigated. The intensity of staining increased with the degree of dedifferentiation. Detection of cytokeratin with monoclonal antibodies was successful in over 80% of samples. All squamous cell carcinomas of the bladder were strongly positive for keratin and cytokeratin. CEA was found in 20% of the G1 and 40% of the G2 and G3 carcinomas of the bladder. Both the prostatic epithelium markers PSA and PAP and the monoclonal antibody Ca1 were negative in all cases.
Similar content being viewed by others
References
Ackermann R (1980) Immunologische Aspekte bei urologischen Tumoren. Med Klin 75:436–441
Ackermann R (1981) Modellsysteme urogenitaler Tumoren des Menschen. Akt Urol 12:52–59
Adolphs HD, Steffen L (1977) Correlation between tumor stage, tumor grade and immunocompetence in patients with carcinoma of the bladder and prostate. Eur Urol 3:23–27
Alsabti EAK, Saffo MH (1979) Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder. Urol Int 34:387–392
Ashall F, Bramwell ME, Harris H (1982) A new marker for human cancer cells. 1. The Ca antigen and the Ca1 antibody. Lancet 32:1–6
Betkerur V, Hlaing V, Baumgartner G, Rao R, Rhee H, Guinan P (1980) Screening tests for detection of bladder cancer. Urology 16:16–19
Catalona WJ (1977) Commentary on immunobiology of bladder cancer. J Urol 118:2–7
Colleen S, Ek A, Gullberg B, Johansson BG, Lindberg LG, Olsson AM (1979) Carcinoembryonic antigen in urine in patients with urothelial carcinoma. Scand J Urol Nephrol 13:149–153
Coombes GB, Hall RR, Laurence DJR, Neville AM (1975) Urinary carcinoembryonic antigen (CEA) — like molecules and urothelial malignancy: A clinical appraisal. Br J Cancer 31:135–142
Denk H, Tappeiner G, Eckerstorfer R, Holzner JH (1972) Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer 10:262–272
Fleisher M, Grabstald H, Whitmore WF, Pinsky CM, Oettgen HF, Schwartz MK (1977) The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. J Urol 117:635–637
Fraser RA, Rarry MJ, Segura JW, Go VLW (1975) Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer. J Urol 114:226–229
Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122:467–481
Gold P, Gold M, Freedman SO (1968) Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res 28:1331–1334
Goldenberg DM, Wahren B (1978) Immunoperoxidase staining of carcinoembryonic antigen in urinary bladder cancer. Urol Res 6:211–214
Guinan P, John T, Sadoughi N, Ablin RJ, Bush I (1974) Urinary carcinoma embryonic — like levels in patients with bladder carcinoma. J Urol 111:350–352
Hall RR, Laurence DJR, Neville AM, Wallace DM (1973) Carcinoembryonic antigen and urothelial carcinoma. Br J Urol 45:88–92
Hering H, Hering FJ, Weidner W (1976) CEA-Bestimmung in Urin und Plasma bei Patienten mit Tumoren des Urogenital-traktes. Urologe (A) 15:300–303
Huland H, Otto U, Droese M (1983) The value of urinary cytology, serum and urinary carcinoembryonic antigen, rheumatoid factors and urinary immunoglobulin concentration as tumor markers or prognostic factors in predicting progression of superficial bladder cancer. Eur Urol 9:346–349
Ionescu G, Romas NA, Ionescu L (1976) Carcinoembryonic antigen and bladder carcinoma. J Urol 115:46–48
Jakse G, Rauschmeier H, Rosmanith P, Hofstädter F (1983) Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder. Urol Int 38:121–125
James K, Alroy J, Miller AW, Flanagan M (1980) Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder. Am J Clin Pathol 73:250–253
Jautzke G, Altenaehr E (1982) Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with Grading and Staging on tissue sections of urinary bladder carcinomas. Cancer 50:2052–2056
Luethgens M, Schlegel G (1981) Verlaufskontrolle mit Tissue Polypeptide Antigen und Carcinoembryonalem Antigen in der radioonkologischen Nachsorge und Therapie. Tumor Diagn 2:179–188
McGee JO'D, Woods JC, Ashall F, Bramwell ME, Harris H (1982) A new marker for human cancer cells. 2. immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody. Lancet 32:7–10
Murphy WM, Vandevoorde JP, Rao MP, Soloway M (1977) The clinical value of urinary carcinoembryonic antigen — like substances in urothelial cancer. J Urol 118:806–808
Naritoku WY, Taylor CR (1982) A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: An evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase. J Histochem Cytochem 30:253–260
Oehr P, Schlösser T, Adolphs HD (1980) Anwendbarkeit eines enzymatischen Tests zur Bestimmung von CEA im Serum und CEA-ähnlichen Substanzen im Urin bei Patienten mit Harn-blasentumoren. Tumor Diagn 1:40–44
Orjasaeter H, Fossa SD, Schjolseth SA, Fjaestad K (1978) Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of bladder/urethra. Cancer 42:287–295
Ramaekers F, Puts J, Mosker O, Kant A, Jap P, Vooijs P (1983) Demonstration of keratin in human adenocarcinomas. Am J Pathol 111:213–223
Reynoso G, Chu TM, Guinan P, Murphy GP (1972) Carcinoembryonic antigen in patients with tumors of the urogenital tract. Cancer 30:1–4
Rost A, Kneppenberg K, Rost P (1976) Wertigkeit des Carcinoembryonalen Antigens (CEA) für die Diagnostik maligner Tumoren des Urogenitaltraktes. Helv Chir Acta 43:271–278
Schlegel R, Banks-Schlegel S, Pinkus GS (1980) Immunohistochemical localization of keratin in normal human tissues. Lab Invest 42:91–96
Schlegel R, Banks-Schlegel S, McLeod JA, Pinkus GS (1980) Immunoperoxidase localization of keratin in human neoplasmas. Am J Pathol 101:41–50
Shevchuk MM, Fenoglio RM, Richart RM (1981) Carcinoembryonic antigen localization in benign and malignant transitional epithelium. Cancer 47:899–905
Steffens J, Friedmann W, Lobeck H, Nagel R, Blümcke S (1985) Immunhistochemische Darstellung von tumorassoziierten Antigenen bei Prostatakarzinomen unterschiedlicher Differenzierungsrade. Tumor Diagn Ther (in press)
Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG (1970) The unlabeled antibody enzyme method of immunohistochemistry. Preparations and properties of soluble antigen-antibody complex (horseradish peroxidase-anti-horseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18:315–333
Tailly G, Cornelissen M, Vereecken RL, Verduyn H, Devos P, De Roo M (1983) Urinary carcinoembryonic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma. Br J Urol 55:501–507
Turner AG, Carter S, Higgins E, Glashan RW, Neville AM (1977) The clinical diagnostic value of the carcinoembryonic antigen (CEA) in hematuria. Br. J Urol 49:61–66
Wahren B, Edsmyr F, Zimmerman R (1975) Measurement of urinary CEA — like activity. Cancer 36:1490–1495
Wahren B, Eposti P, Zimmerman R (1977) Characterization of urothelial carcinoma with respect to the content of carcinoembryonic antigen in exfoliated cells. Cancer 40:1511–1518
Wajsman Z, Merrin CE, Chu TM, Moore RH, Murphy GP (1975) Evaluation of biological markers in bladder cancer. J Urol 114: 879–883
Wilson PD, Nathrath WBJ, Trejdosiewicz LK (1982) Immunoelectron microscopic localization of keratin and luminal epithelial antigens in normal and neoplastic urothelium. Pathol Res Pract 175:289–298
Zacher G, Weidner W, Krause W, Rothauge CF (1979) Urinary levels of carcinoembryonic antigen in bladder carcinoma. In: Lehmann FG (ed) Carcinoembryonic proteins vol 2. Elsevier/North Holland Biomedical Press, pp 201–204
Zimmerman R, Wahren B, Edsmyr F (1980) Assessment of serial CEA determination in urine of patients with bladder carcinoma. Cancer 46:1802–1809
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steffens, J., Friedmann, W. & Lobeck, H. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder. Urol. Res. 13, 55–59 (1985). https://doi.org/10.1007/BF00261566
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00261566